About Portal Instruments
Portal Instruments is a Cambridge, MA-based medical device company founded in 2012 out of the MIT BioInstrumentation Laboratory, developing a needle-free and needle-based drug delivery platform (PRIME) for high-viscosity biologics. Their technology uses computer-controlled jet technology to administer medications through the skin without traditional needles, targeting patients with chronic diseases who self-inject. The company partners with biopharma organizations to provide differentiated drug/device combination products and life-cycle management solutions.
Company details
Funding
Total raised
$49.7M
Last stage
Series C
Investors
Founders
Patrick Anquetil
PhD/MBA; 18+ years leading high-tech bioengineering companies. Previously co-founded SynapDx Corporation and Aretais, Inc. Founded Portal Instruments in 2012 based on MIT research.
Ian W. Hunter
Hatsopoulos Professor of Mechanical Engineering and Head of the Bio Instrumentation Laboratory at MIT. World-renowned inventor and scientist whose lab originated Portal Instruments' core needle-free injection technology.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.